Jose Estevam
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Protein Degradation and Inhibitors 7
- Cancer therapeutics and mechanisms 2
-
- Multiple Myeloma Research and Treatments 9
- Co-authors
- Paul G. Richardson (5 shared papers)Shaji Kumar (3 shared papers)S. Vincent Rajkumar (3 shared papers)A. Keith Stewart (3 shared papers)Parameswaran Hari (3 shared papers)Hongliang Shi (2 shared papers)George Mulligan (2 shared papers)Jeffrey L. Wolf (2 shared papers)
- Journals
- Blood (8 papers)Cytometry Part B Clinical Cytometry (2 papers)British Journal of Clinical Pharmacology (1 paper)PLoS ONE (1 paper)Annual Review of Biomedical Engineering (1 paper)
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Jose Estevam
16 papers receiving 742 citations
Peers
Comparison fields: 5 of 54
- Hematology 615
- Oncology 286
- Molecular Biology 454
- Genetics 64
- Physiology 12
Countries citing papers authored by Jose Estevam
This map shows the geographic impact of Jose Estevam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Estevam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Estevam more than expected).
Fields of papers citing papers by Jose Estevam
This network shows the impact of papers produced by Jose Estevam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Estevam. The network helps show where Jose Estevam may publish in the future.
Co-authors
The 25 scholars most cited alongside Jose Estevam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 319 | |
| 2 | 2014 | 204 | |
| 3 | 2020 | 36 | |
| 4 | 2022 | 29 | |
| 5 | 2013 | 28 | |
| 6 | 2010 | 27 | |
| 7 | 2018 | 27 | |
| 8 | 2015 | 24 | |
| 9 | 2018 | 21 | |
| 10 | 2018 | 18 | |
| 11 | 2010 | 12 | |
| 12 | 2018 | 6 | |
| 13 | 2021 | 4 | |
| 14 | 2024 | 4 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2022 | 0 |
About Jose Estevam
Jose Estevam is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 764 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Cancer therapeutics and mechanisms (2 papers), Calcium signaling and nucleotide metabolism (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hematology (615 citations), Oncology (286 citations), Molecular Biology (454 citations), Genetics (64 citations) and Physiology (12 citations). Jose Estevam has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Paul G. Richardson, Shaji Kumar, S. Vincent Rajkumar, A. Keith Stewart, Parameswaran Hari, Hongliang Shi, George Mulligan, Jeffrey L. Wolf, Robert M. Rifkin and Natalie S. Callander. Their work appears in journals such as Blood, Cytometry Part B Clinical Cytometry, British Journal of Clinical Pharmacology, PLoS ONE and Annual Review of Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.